Levisonics develops medical devices for rapid blood coagulation and fluid analysis using acoustic levitation technology. The company's flagship product, the Acoustic Tweezing Coagulation Analyzer, performs viscoelastic and optical measurements on blood droplets without surface contact, enabling point-of-care testing outside traditional hospital settings.
The device requires 60 times less blood than competing solutions and works with both venous and capillary samples, delivering results in real time. This efficiency makes it particularly suited for trauma care and field diagnostics. The company was founded through a partnership between CEO Nithya Kasireddy and researchers from Tulane University and Boston University, bringing academic rigor to a practical clinical problem.
Levisonics has received a $4.3 million grant from the U.S. Department of Defense under the Technology/Therapeutic Development Award to develop point-of-care diagnosis and management tools for trauma patients. The company is based in Fishers, Indiana, and has been recognized as one of the most promising early-stage startups in the state.
